ASYMCHEM LAB.(TIAN.)H YC1 (F:7K90) — Market Cap & Net Worth
Market Cap & Net Worth: ASYMCHEM LAB.(TIAN.)H YC1 (7K90)
ASYMCHEM LAB.(TIAN.)H YC1 (F:7K90) has a market capitalization of $559.71 Million (€478.75 Million) as of September 17, 2026. Listed on the F stock exchange, this Germany-based company holds position #11678 globally and #1309 in its home market, demonstrating a 21.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ASYMCHEM LAB.(TIAN.)H YC1's stock price €17.20 by its total outstanding shares 27834510 (27.83 Million). Also see ASYMCHEM LAB.(TIAN.)H YC1 (7K90) total assets for a full breakdown of the balance sheet.
ASYMCHEM LAB.(TIAN.)H YC1 Market Cap History: 2022 to 2026
ASYMCHEM LAB.(TIAN.)H YC1's market capitalization history from 2022 to 2026. Data shows growth from $243.91 Million to $559.71 Million (6.88% CAGR). Also see ASYMCHEM LAB.(TIAN.)H YC1 (7K90) cash flow conversion for how efficiently the company converts equity into cash flow.
ASYMCHEM LAB.(TIAN.)H YC1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ASYMCHEM LAB.(TIAN.)H YC1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ASYMCHEM LAB.(TIAN.)H YC1 stock quote for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.04x
ASYMCHEM LAB.(TIAN.)H YC1's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.22x
ASYMCHEM LAB.(TIAN.)H YC1's market cap is 0.22 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $243.91 Million | $10.26 Billion | $3.30 Billion | 0.02x | 0.07x |
| 2023 | $228.60 Million | $7.83 Billion | $2.27 Billion | 0.03x | 0.10x |
| 2024 | $208.27 Million | $5.80 Billion | $948.95 Million | 0.04x | 0.22x |
| 2025 | $247.32 Million | $6.67 Billion | $1.13 Billion | 0.04x | 0.22x |
Competitor Companies of 7K90 by Market Capitalization
Companies near ASYMCHEM LAB.(TIAN.)H YC1 in the global market cap rankings as of September 17, 2026. Review ASYMCHEM LAB.(TIAN.)H YC1 tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to ASYMCHEM LAB.(TIAN.)H YC1 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #186 globally with a market cap of $130.44 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.29 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.82 Billion USD ( AU$84.54 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #506 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #186 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.44 Billion | $514.63 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.29 Billion | $774.11 |
| #457 | CSL Ltd | AU:CSL | $59.82 Billion | AU$174.26 |
| #506 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $143.77 |
ASYMCHEM LAB.(TIAN.)H YC1 Historical Marketcap From 2022 to 2026
Between 2022 and today, ASYMCHEM LAB.(TIAN.)H YC1's market cap moved from $243.91 Million to $ 559.71 Million, with a yearly change of 6.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €559.71 Million | +126.32% |
| 2025 | €247.32 Million | +18.75% |
| 2024 | €208.27 Million | -8.89% |
| 2023 | €228.60 Million | -6.28% |
| 2022 | €243.91 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of ASYMCHEM LAB.(TIAN.)H YC1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $559.71 Million USD |
| MoneyControl | $559.71 Million USD |
| MarketWatch | $559.71 Million USD |
| marketcap.company | $559.71 Million USD |
| Reuters | $559.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ASYMCHEM LAB.(TIAN.)H YC1
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, incl… Read more